Supply Chain Intelligence

Neuphoria Therapeutics Inc. Supply Chain

NEUP supply chain intelligence for Neuphoria Therapeutics Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

NEUP ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
6Customers
1Debt Items
20Related Chains

Neuphoria Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
MERCK-SHARP-DOHME-CORP MERCK-SHARP-DOHME-CORP 92% we granted MSD (i) an exclusive (even as to us and our affiliates), worldwide, sublicensable license under certain of our patent rights and know-how to research, develop, make, have made, use, offer …
CARINA-BIOTECH CARINA-BIOTECH 90% we granted Carina Biotech an exclusive, worldwide license, with the right to grant sublicenses
CMOS CMOS 90% expenses incurred under agreements with third parties, including CROs that conduct research, preclinical activities and clinical trials on our behalf as well as CMOs that manufacture our product cand…
CROS CROS 90% expenses incurred under agreements with third parties, including CROs that conduct research, preclinical activities and clinical trials on our behalf as well as CMOs that manufacture our product cand…
IRWD Ironwood Pharmaceuticals, Inc. 72% obtain regulatory approvals, manufacture a commercial scale product, or arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary for successful product com…
IRWD Ironwood Pharmaceuticals, Inc. 72% Reciprocal relationship from IRWD graph: Reciprocal relationship from NEUP graph: obtain regulatory approvals, manufacture a commercial scale product, or arrange for a third party to do so on our beh…

Neuphoria Therapeutics Inc. Customers

TickerNameConfidenceEvidence
CARINA-BIOTECH CARINA-BIOTECH 92% On October 30, 2024, Carina made a milestone payment to the Company in the gross amount of A$1,000,000 which was recorded as revenue during the nine months ended March 31, 2025.
MRK Merck & Co., Inc. 85% Reciprocal relationship from MRK graph: Reciprocal relationship from NEUP graph: Reciprocal relationship from MRK graph: Reciprocal relationship from NEUP graph: the Carina Biotech License, and $67.9…
MRK Merck & Co., Inc. 85% the Carina Biotech License, and $67.9 million from Australian research and development credits and government grants and assistance.
IRWD Ironwood Pharmaceuticals, Inc. 72% obtain regulatory approvals, manufacture a commercial scale product, or arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary for successful product com…
IRWD Ironwood Pharmaceuticals, Inc. 72% Reciprocal relationship from IRWD graph: Reciprocal relationship from NEUP graph: Reciprocal relationship from IRWD graph: Reciprocal relationship from NEUP graph: Reciprocal relationship from IRWD g…
ARMISTICE-CAPITAL-MASTER-FUND-LTD ARMISTICE-CAPITAL-MASTER-FUND-LTD 62% n the warrant and contingent consideration liabilities, and a $3.1 million year-over-year change in working capital. Investing Activities There were no transactions categorized as investing activitie…

Neuphoria Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
NEUP-DEBT-11227 Warrants outstanding: 409 90% xbrl warrant detail from xbrl 2025-06-30.

Neuphoria Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Neuphoria Therapeutics Inc..

Neuphoria Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
NEUP-OWNER-LYNX1-CAPITAL-MANAGEMENT-LP Lynx1 Capital Management LP 90% 13F overlay lists Lynx1 Capital Management LP as top holder; 19 tracked holders.

Neuphoria Therapeutics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JAGX Jaguar Health, Inc. 100.00 2
MGNX MacroGenics, Inc. 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2
IBIO iBio, Inc. 100.00 2
MCUJF Medicure Inc. 100.00 2
ADAG Adagene Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
TBPH Theravance Biopharma, Inc. 100.00 2
IBRX ImmunityBio, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
IMMP Immutep Limited 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
EVAX Evaxion A/S 100.00 2
ENLV Enlivex Ltd. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
MRNA Moderna, Inc. 100.00 2
View NEUP supply chain intel →

Explore the full interactive supply chain map for Neuphoria Therapeutics Inc..

Open NEUP supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map